BianchiD.W.2010. From Michael to microarrays: 30 years of studying fetal cells and nucleic acids in maternal blood. Prenat. Diagn., 30:622–623.
2.
BoyleM.P., EnkeR.A., AdamsR.J.et al.2001. In utero AAV-mediated gene transfer to rabbit pulmonary epithelium. Mol. Ther., 4:115–121.
3.
DavidA.L., PeeblesD.M., GregoryL.et al.2006a. Clinically applicable procedure for gene delivery to fetal gut by ultrasound-guided gastric injection: Toward prenatal prevention of early-onset intestinal diseases. Hum. Gene Ther, 17:767–779.
4.
DavidA.L., WeiszB., GregoryL.et al.2006b. Ultrasound-guided injection and occlusion of the trachea in fetal sheep. Ultrasound Obstet. Gynecol, 28:82–88.
5.
DavidA.L., McIntoshJ., PeeblesD.M.et al.2011. Recombinant adeno-associated virus-mediated in utero gene transfer gives therapeutic transgene expression in the sheep. Hum. Gene Ther, 22:419–426.
6.
DeprestJ., GratacosE., NicolaidesK.H.2004. Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: Evolution of a technique and preliminary results. Ultrasound Obstet. Gynecol., 24:121–126.
7.
EndoM., Henriques-CoelhoT., ZoltickP.W.et al.2010. The developmental stage determines the distribution and duration of gene expression after early intra-amniotic gene transfer using lentiviral vectors. Gene Ther., 17:61–71.
8.
MossR.B., RodmanD., SpencerL.T.et al.2004. Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest, 125:509–521.
9.
OrlandiF., DamianiG., JakilC.et al.1990. The risks of early cordocentesis (12–21 weeks): Analysis of 500 procedures. Prenat. Diagn., 10:425–428.
10.
PoradaC.D., ParkP., Almeida-PoradaG., ZanjaniE.D.2004. The sheep model of in utero gene therapy. Fetal Diagn. Ther., 19:23–30.
11.
PoradaC.D., ParkP.J., Almeida-PoradaG.et al.2005. Gestational age of recipient determines pattern and level of transgene expression following in utero retroviral gene transfer. Mol. Ther., 11:284–293.
12.
SabatinoD.E., MackenzieT.C., PeranteauW.et al.2007. Persistent expression of hF.IX after tolerance induction by in utero or neonatal administration of AAV-1-F.IX in hemophilia B mice. Mol. Ther., 15:1677–1685.
13.
StitelmanD.H., EndoM., BoraA.et al.2010. Robust in vivo transduction of nervous system and neural stem cells by early gestational intra amniotic gene transfer using lentiviral vector. Mol. Ther., 18:1615–1623.
14.
ThurleyD.C.1973. Growth of the Romney sheep foetus. N. Z. J. Agric. Res., 16:111–114.
15.
TranN.D., PoradaC.D., Almeida-PoradaG.et al.2001. Induction of stable prenatal tolerance to β-galactosidase by in utero gene transfer into preimmune sheep fetuses. Blood, 97:3417–3423.
16.
UptonR.N.2008. Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling. J. Pharmacol. Toxicol. Methods, 58:198–205.
17.
WaddingtonS.N., NivsarkarM.S., MistryA.R.et al.2004. Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. Blood, 104:2714–2721.
